Although studies show the role of T regulatory (Treg) cells in suppressing the efficacy of the antitumor GM-CSF vaccine against B16 melanoma [44], the changes in the Treg frequencies in the present study were not significant after one dose, three doses, and five doses of irradiated TC-1/cGM-CSF vaccination. The gene discussed is CSF2; the disease is melanoma.